![Deya Corzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Deya Corzo worked as an Executive Director-Medical at Celgene Corp.
from 2012 to 2014.
She then worked as SVP-Research & Development, Head-Therapeutic Area at uniQure NV from 2014 to 2017.
From 2017 to 2018, she served as Chief Medical Officer at Sojournix, Inc. and from 2018 to 2021, she worked as Chief Medical Officer at Sigilon Therapeutics, Inc. Dr. Corzo holds a doctorate degree from Universidad Industrial de Santander.
Precedenti posizioni note di Deya Corzo
| Società | Posizione | Fine |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2021 |
Sojournix, Inc.
 Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
| UNIQURE N.V. | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
| CELGENE | Corporate Officer/Principal | 01/01/2014 |
Formazione di Deya Corzo
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
38
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Universidad Industrial de Santander
 Universidad Industrial de Santander Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
